Parathyroid  	Parathyroid  	 JJ	B-NP
hormone  	hormone  	 NN	I-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
analogues  	analogues  	 NN	O
-  	-  	 :	O
molecular  	molecular  	 JJ	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
of  	of  	 IN	O
action  	action  	 NN	O
and  	and  	 CC	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
osteoporosis  	osteoporosis  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
Most  	Most  	 RBS	O
medical  	medical  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
currently  	currently  	 RB	O
applied  	applied  	 VBN	O
in  	in  	 IN	O
osteoporosis  	osteoporosis  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
act  	act  	 NN	I-NP
by  	by  	 IN	O
inhibiting  	inhibiting  	 JJ	O
bone  	bone  	 NN	B-NP
resorption  	resorption  	 NNS	I-NP
and  	and  	 CC	O
reducing  	reducing  	 VBG	B-NP
bone  	bone  	 NN	I-NP
remodelling 	remodelling 	 NN	I-NP
,  	,  	 ,	O
i.e.  	i.e.  	 VBZ	O
they  	they  	 PRP	O
inhibit  	inhibit  	 VBP	O
the  	the  	 DT	O
process  	process  	 NN	O
of  	of  	 IN	O
bone  	bone  	 NN	O
mass  	mass  	 NN	O
loss  	loss  	 NN	O
by  	by  	 IN	O
suppressing  	suppressing  	 JJ	O
bone  	bone  	 NN	B-NP
resorption  	resorption  	 NN	I-NP
processes 	processes 	 NNS	I-NP
.  	.  	 .	O
These  	These  	 DT	O
drugs  	drugs  	 NNS	O
provide  	provide  	 VBP	O
an  	an  	 DT	O
ideal  	ideal  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
option  	option  	 NN	I-NP
to  	to  	 TO	O
prevent  	prevent  	 VB	O
osteoporosis  	osteoporosis  	 JJ	B-NP
progression 	progression 	 NN	I-NP
.  	.  	 .	O
They  	They  	 PRP	O
however  	however  	 RB	O
have  	have  	 VB	O
a  	a  	 DT	O
rather  	rather  	 RB	O
limited  	limited  	 JJ	O
usefulness  	usefulness  	 NN	O
when  	when  	 WRB	O
the  	the  	 DT	O
disease  	disease  	 NN	O
has  	has  	 VBZ	O
already  	already  	 RB	O
reached  	reached  	 VBN	O
its  	its  	 PRP$	O
advanced  	advanced  	 JJ	O
stages  	stages  	 NNS	O
with  	with  	 IN	O
distinctive  	distinctive  	 JJ	B-NP
bone  	bone  	 NN	I-NP
architecture  	architecture  	 NN	I-NP
lesions 	lesions 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
fracture  	fracture  	 JJ	B-NP
risk  	risk  	 NN	I-NP
reduction  	reduction  	 NN	I-NP
rate 	rate 	 NN	I-NP
,  	,  	 ,	O
achieved  	achieved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
course  	course  	 NN	O
of  	of  	 IN	O
anti-resorptive  	anti-resorptive  	 JJ	B-NP
therapy 	therapy 	 NN	I-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
insufficient  	insufficient  	 JJ	O
for  	for  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
severe  	severe  	 JJ	O
osteoporosis  	osteoporosis  	 NN	B-NP
to  	to  	 TO	O
stop  	stop  	 VB	O
the  	the  	 DT	O
downward  	downward  	 JJ	O
spiral  	spiral  	 NN	O
of  	of  	 IN	O
their  	their  	 PRP$	O
quality  	quality  	 NN	B-NP
of  	of  	 IN	I-NP
life  	life  	 NN	I-NP
( 	( 	 -LRB-	O
QoL 	QoL 	 NNP	B-NP
)  	)  	 -RRB-	O
with  	with  	 IN	O
a  	a  	 DT	O
simultaneously  	simultaneously  	 RB	O
increasing  	increasing  	 VBG	B-NP
threat  	threat  	 NN	I-NP
of  	of  	 IN	O
premature  	premature  	 JJ	O
death 	death 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
N-terminal  	N-terminal  	 JJ	B-NP
fragment  	fragment  	 NN	I-NP
of  	of  	 IN	O
1-34  	1-34  	 CD	O
human  	human  	 JJ	O
parathormone  	parathormone  	 NNS	B-NP
( 	( 	 -LRB-	O
teriparatide  	teriparatide  	 NN	B-NP
-  	-  	 :	O
1-34  	1-34  	 NNP	O
rhPTH 	rhPTH 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
parathyroid  	parathyroid  	 JJ	B-NP
hormone  	hormone  	 NN	I-NP
( 	( 	 -LRB-	O
PTH 	PTH 	 NNP	B-NP
)  	)  	 -RRB-	O
analogue  	analogue  	 VBZ	O
obtained  	obtained  	 VBN	O
via  	via  	 IN	O
genetic  	genetic  	 JJ	B-NP
engineering  	engineering  	 NN	I-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
expressed  	expressed  	 VBN	O
by  	by  	 IN	O
increased  	increased  	 JJ	O
bone  	bone  	 NN	O
metabolism 	metabolism 	 NN	O
,  	,  	 ,	O
while  	while  	 IN	O
promoting  	promoting  	 VBG	O
new  	new  	 JJ	O
bone  	bone  	 NN	O
tissue  	tissue  	 NN	O
formation  	formation  	 NN	O
by  	by  	 IN	O
stimulating  	stimulating  	 VBG	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
osteoblasts  	osteoblasts  	 VBG	O
more  	more  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
osteoclasts 	osteoclasts 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
anabolic  	anabolic  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
PTH  	PTH  	 NNP	I-NP
includes  	includes  	 VBZ	O
both  	both  	 PDT	O
its  	its  	 PRP$	O
direct  	direct  	 JJ	O
effect  	effect  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
osteoblast  	osteoblast  	 JJ	B-NP
cell  	cell  	 NN	I-NP
line 	line 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
its  	its  	 PRP$	O
indirect  	indirect  	 JJ	O
actions  	actions  	 NNS	O
exerted  	exerted  	 VBN	O
via  	via  	 IN	O
its  	its  	 PRP$	O
regulatory  	regulatory  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
on  	on  	 IN	O
selected  	selected  	 JJ	O
growth  	growth  	 NN	B-NP
factors 	factors 	 NNS	I-NP
,  	,  	 ,	O
e.g.  	e.g.  	 NNP	O
IGF-1  	IGF-1  	 NNP	B-NP
or  	or  	 CC	O
sclerostin 	sclerostin 	 NN	B-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
molecular  	molecular  	 JJ	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
responsible  	responsible  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
actual  	actual  	 JJ	O
anabolic  	anabolic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
PTH  	PTH  	 NNP	I-NP
remain  	remain  	 VBP	O
mostly  	mostly  	 RB	O
still  	still  	 RB	O
unclear 	unclear 	 JJ	O
.  	.  	 .	O
Clinical  	Clinical  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
demonstrated  	demonstrated  	 VBN	O
that  	that  	 IN	O
therapeutic  	therapeutic  	 JJ	B-NP
protocols  	protocols  	 NNS	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
application  	application  	 NN	O
of  	of  	 IN	O
PTH  	PTH  	 NNP	B-NP
analogues  	analogues  	 NNS	I-NP
provide  	provide  	 VBP	O
an  	an  	 DT	O
effective  	effective  	 JJ	O
protection  	protection  	 NN	O
against  	against  	 IN	O
all  	all  	 DT	O
osteoporotic  	osteoporotic  	 JJ	B-NP
fracture  	fracture  	 NN	I-NP
types  	types  	 NNS	I-NP
in  	in  	 IN	O
post-menopausal  	post-menopausal  	 JJ	B-NP
women  	women  	 NNS	I-NP
and  	and  	 CC	O
in  	in  	 IN	O
elderly  	elderly  	 JJ	O
men  	men  	 NNS	O
with  	with  	 IN	O
advanced  	advanced  	 JJ	O
osteoporosis 	osteoporosis 	 NN	B-NP
.  	.  	 .	O
Particular  	Particular  	 JJ	B-NP
hopes  	hopes  	 NNS	I-NP
are  	are  	 VBP	O
pinned  	pinned  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
of  	of  	 IN	O
applying  	applying  	 VBG	B-NP
PTH  	PTH  	 NNP	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
therapy  	therapy  	 NN	O
of  	of  	 IN	O
post-steroid  	post-steroid  	 JJ	B-NP
osteoporosis 	osteoporosis 	 NN	I-NP
,  	,  	 ,	O
mainly  	mainly  	 RB	O
to  	to  	 TO	O
suppress  	suppress  	 VB	O
bone  	bone  	 JJ	O
formation 	formation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
most  	most  	 RBS	O
important  	important  	 JJ	O
pathological  	pathological  	 JJ	B-NP
process  	process  	 NN	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
regard 	regard 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
relatively  	relatively  	 RB	O
short  	short  	 JJ	O
therapy  	therapy  	 NN	B-NP
period  	period  	 NN	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
PTH  	PTH  	 NNP	B-NP
analogue  	analogue  	 NNS	I-NP
( 	( 	 -LRB-	O
24  	24  	 CD	O
months 	months 	 NNS	O
)  	)  	 -RRB-	O
should  	should  	 MD	O
then  	then  	 RB	O
be  	be  	 VB	O
replaced  	replaced  	 VBN	O
and  	and  	 CC	O
continued  	continued  	 VBD	O
by  	by  	 IN	O
anti-resorptive  	anti-resorptive  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
.  	.  	 .	O
